Concentrations of gonadotrophins and steroids in pre-ovulatory follicular fluid and serum in relation to stimulation protocol and outcome of assisted reproduction treatment.
In this prospective, randomized study, concentrations of gonadotrophins and steroids in pre-ovulatory follicular fluid (FF) and serum were related to type of stimulation protocol as well as to the outcome of assisted reproduction in 280 women subjected to the long protocol gonadotrophin-releasing hormone (GnRH) agonist pituitary down-regulation and ovarian stimulation with either human menopausal gonadotrophin (HMG) or recombinant FSH. In the women treated with HMG, concentrations of LH, FSH, oestradiol and androstenedione in FF were significantly higher, and those of human chorionic gonadotrophin (HCG) and progesterone significantly lower, than in the women treated with recombinant FSH (rFSH). More women became pregnant and delivered in the HMG than in the rFSH group. These differences, however, were not statistically significant. Concentrations of FSH in serum and of FSH and LH in FF were significantly higher in conception than in non-conception cycles, whereas all other hormone concentrations in FF and serum were similar. The present study demonstrates that the pre-ovulatory follicular fluid hormone profile is significantly influenced by the gonadotrophin preparation used for ovarian stimulation, and suggests that ovarian stimulation with HMG results in an intra-follicular hormone profile more similar to that characterizing conception cycles than stimulation with rFSH. However, as the present data represent means of FF hormone profiles, they do not allow the conclusion of a direct correlation between the intra-follicular concentration of a certain hormone and the ability of the corresponding embryo to implant and establish an ongoing pregnancy.
Westergaard
L G
LG
Fertility Clinic, Odense University Hospital, DK-5000 Odense C, Denmark.
Erb
K
K
Laursen
S B
SB
Rasmussen
P E
PE
Rex
S
S
Westergaard
C G
CG
Andersen
C Yding
CY
D002064:Buserelin / Q000494:pharmacology; D005260:Female; D005300:Fertility Agents, Female / Q000494:pharmacology; D005307:Fertilization in Vitro; D015571:Follicular Fluid / Q000378:metabolism*; D006062:Gonadotropins / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D009865:Oocytes / Q000378:metabolism; D006080:Ovarian Follicle / Q000187:drug effects; D011446:Prospective Studies; D020554:Sperm Injections, Intracytoplasmic; D013256:Steroids / Q000097:blood / Q000378:metabolism*
D005300:Fertility Agents, Female; D006062:Gonadotropins; D013256:Steroids; D002064:Buserelin